Hepatitis D Clinical Trials in Clermont-Ferrand
2 recruitingClermont-Ferrand, France
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)
Chronic Hepatitis D Infection
Mirum Pharmaceuticals, Inc.172 enrolled44 locationsNCT07200908
Recruiting
National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses
Hepatitis B, ChronicHepatitis D, Chronic
ANRS, Emerging Infectious Diseases800 enrolled38 locationsNCT04166266